AptarGroup, Inc (ATR) FY2026 YTD Q2 P&L / Income Statement

Published Source: Form 10-Q on SEC EDGAR filed (opens in a new tab)

Revenue by Business Segment by Geography

Swipe to see the full flow
AptarGroup, Inc (ATR) FY2026 YTD Q2 P&L / Income StatementIncome statement for 2026-01-01 through 2026-06-30. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUEGROSSOPERATINGPRE-TAXNETPharma - EuropeBeauty - EuropePharma - DomesticClosures - DomesticClosures - EuropeBeauty - DomesticPharma - AsiaBeauty - Latin AmericaBeauty - AsiaClosures - Latin AmericaPharma - Latin AmericaClosures - AsiaNet SalesGross profit (calculated)Cost of revenue (calculated)Cost of sales (exclusive of depreciation and amortization shown below)Operating IncomeOperating expenses (calculated)Selling, research & development and administrativeDepreciation and amortizationRestructuring initiativesIncome before Income TaxesOther income (expense), net (calculated)Net IncomeProvision for Income TaxesGross profit (calculated)Gross profit(calculated)$717.43 MIncome before Income TaxesIncome beforeIncome Taxes$208.82 MNet SalesNet Sales$2.01 BOperating IncomeOperating Income$234.22 MNet IncomeNet Income$160.78 MPharma - EuropePharma - Europe$457.42 MOperating expenses (calculated)Operating expenses(calculated)$483.21 MProvision for Income TaxesProvision forIncome Taxes$48.04 MBeauty - EuropeBeauty - Europe$444.05 MSelling, research & development and administrativeSelling, research &development and administrative$325.34 MOther income (expense), net (calculated)Other income,net (calculated)−$25.40 MCost of revenue (calculated)Cost of revenue(calculated)$1.29 BPharma - DomesticPharma - Domestic$285.17 MDepreciation and amortizationDepreciation and amortization$155.37 MClosures - DomesticClosures - Domestic$169.53 MRestructuring initiativesRestructuring initiatives$2.51 MClosures - EuropeClosures - Europe$130.41 MCost of sales (exclusive of depreciation and amortization shown below)Cost of sales$1.29 BBeauty - DomesticBeauty - Domestic$117.11 MPharma - AsiaPharma - Asia$114.90 MBeauty - Latin AmericaBeauty - Latin America$88.47 MBeauty - AsiaBeauty - Asia$81.46 MClosures - Latin AmericaClosures - Latin America$43.32 MPharma - Latin AmericaPharma - Latin America$39.24 MClosures - AsiaClosures - Asia$38.29 M
Chart details

AptarGroup, Inc (ATR) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net Sales
2,009,376,000 US dollars
Cost of revenue (calculated)
1,291,950,000 US dollars
Gross profit (calculated)
717,426,000 US dollars
Operating expenses (calculated)
483,208,000 US dollars
Operating Income
234,218,000 US dollars
Other income (expense), net (calculated)
negative 25,400,000 US dollars
Income before Income Taxes
208,818,000 US dollars
Provision for Income Taxes
48,041,000 US dollars
Net Income
160,777,000 US dollars
Beauty - Asia
81,461,000 US dollars
Beauty - Europe
444,054,000 US dollars
Beauty - Latin America
88,466,000 US dollars
Beauty - Domestic
117,108,000 US dollars
Closures - Asia
38,292,000 US dollars
Closures - Europe
130,414,000 US dollars
Closures - Latin America
43,320,000 US dollars
Closures - Domestic
169,534,000 US dollars
Pharma - Asia
114,903,000 US dollars
Pharma - Europe
457,417,000 US dollars
Pharma - Latin America
39,242,000 US dollars
Pharma - Domestic
285,165,000 US dollars
Cost of sales (exclusive of depreciation and amortization shown below)
1,291,950,000 US dollars
Selling, research & development and administrative
325,337,000 US dollars
Depreciation and amortization
155,366,000 US dollars
Restructuring initiatives
2,505,000 US dollars

Chart connections

  • Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
  • Of which attributable to AptarGroup, Inc: $160.25 M; to noncontrolling interests: $530.00 K.
AptarGroup, Inc (ATR) FY2026 YTD Q2 P&L / Income Statement Sankey chart, Segments by Geographical view
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!